Strategic Plan

disabled man plays with his daughter
October 29, 2015

Compound developed at VUMC may delay Huntington’s disease

A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder.

By Bill Snyder
October 29, 2015

Study explores nicotine patch to treat memory loss

Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.

By Nancy Humphrey
October 29, 2015

Investigators find clues to melanoma treatment resistance

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

By VUMC News and Communications
October 29, 2015

ICU Recovery Center helps ease burden of critical illness

Quinton Smith doesn’t remember much of what happened one Sunday evening last March. He was disoriented, unable to stand and could not even recognize his girlfriend’s face after she returned home from work.

By VUMC News and Communications
images from a brain scan
October 22, 2015

Guillamondegui: One standard needed to track concussions

Data in sports concussion studies will continue to be disputed as long as the injuries are diagnosed by differing standards instead of universal guidelines, a Vanderbilt investigator concludes in a recent review.

By Tom Wilemon
October 22, 2015

VU-invented wireless ECG system receives FDA approval

A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval.

By VUMC News and Communications